Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Assessing Anticholinergic Burden

August 5, 2025

HMP · Assessing Anticholinergic Burden

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional

Chelsie Monroe, APN, PMHNP-BC explores anticholinergic burden and how to measure its cognitive impact in clinical care.

Related Content

Can Anticholinergic Medications Make Movement Disorders Worse?
Understanding the Cholinergic System
Treatment Options and Managing Side Effects in Schizophrenia
What’s the Role of Amantadine in Anticholinergic Deprescription?
Anticholinergic Misuse: Can These Medications Be Addictive?
Assessing Anticholinergic Burden
Case Managers, Telepsychiatry Offer Consistency in Schizophrenia Treatment
© 2025 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy